ArticleFrontiers in endocrinology2026
Local co-expression of GLP1R and INS in human cortical interneurons.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims/hypothesis: Emerging evidence suggests that glucagon-like peptide-1 receptor (GLP1R) and insulin (INS), traditionally associated with peripheral metabolic regulation, also exert key functions in the central nervous system. We hypothesised that specific human cortical interneuron subtypes locally express GLP1R and INS, a molecular feature that may be relevant for exploring potential intracortical metabolic signalling mechanisms. Methods: We analysed single layer 1 GABAergic interneurons microdissected from human cortical tissue using laser capture microdissection. Transcriptomic subtype identification was performed using digital PCR preamplification of LAMP5, SV2C and PRSS12 markers. GLP1R and INS and mRNA copy numbers were quantified using single-cell digital PCR, and spatial expression patterns were validated using RNAscope Hi-Plex Results: Neurogliaform (LAMP5+, SV2C+, PRSS12-) and rosehip cells (LAMP5+, SV2C+, PRSS12+) exhibited significantly higher GLP1R and INS expression than other LAMP5 interneurons. GLP1R mRNA was found in 44/72 neurogliaform and 18/36 rosehip cells, whereas INS mRNA was detected in 29/72 and 11/36 respectively. No INS expression was detected in other LAMP5 interneurons. Co-expression analysis revealed significant statistical dependency (mutual information = 0.244, p<0.0001), indicating non-random co-expression. Conclusions/interpretation: Human cortical neurogliaform and rosehip interneurons selectively co-express GLP1R and INS, conceptualising the existence of a local intracortical GLP1R- insulin-signalling loop. These findings provide a context for future investigations into cerebral glucose-regulatory processes implicated in certain neurodegenerative conditions, such as mild cognitive impairment in diabetes mellitus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.